TY - JOUR T1 - Is it safe to use a single ventilator for two or more patients? JF - medRxiv DO - 10.1101/2020.07.01.20080556 SP - 2020.07.01.20080556 AU - Sebastián Ugarte Ubiergo AU - Felipe Castillo Merino AU - Óscar Arellano-Pérez Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/07/2020.07.01.20080556.abstract N2 - Mechanical ventilation is essential in the SARS-CoV-2 pandemic context. Considering the limited availability of mechanical ventilators due to high costs increased by global demand, the use of a single ventilator for two or more patients has been encouraged. An experimental model that ventilates two test lungs with a single machine has been designed in order to measure possible asymmetries during parallel circuit ventilation under different lung compliance conditions. This paper reports a first assessment of the risks involved in ventilating two patients with a single machine. Since some volumetric differences are not monitored by the ventilator itself, the main risks involved are distension or alveolar collapse if used in actual patients that have different thoracopulmonary mechanics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external financing was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This report was not carried out on humans, so it was not submitted to an ethics committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesI declare, represent the responsibility together with the three authors, on the good practice in the writing of the manuscript to present. ER -